References

1. Andersson, A. et al. Clinical utility of MRI biomarkers for identifying NASH patients’ high risk of progression: A multi-center pooled data and meta-analysis. Clin Gastroenterol
Hepatol S1542-3565(21)01056–9 (2021). https://doi.org/10.1016/j.cgh.2021.09.041

2. McKay, A. et al. Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway. J Patient Rep Outcomes 5, 89 (2021).
https://doi.org/10.1186/s41687-021-00363-5

3. Jayaswal, A. et al. (2021). Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus. Abdominal radiology (New York), 46(5), 1947–1957. https://doi.org/10.1007/s00261-020-02860-5